SEC Form 4
Imax Corp (IMAX) insider trading
In the 12 months to Oct 24, 2026, 10 IMAX insiders reported open-market sales of $74.7M across 21 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $74.7M
- 21 filings · 10 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 8 of 21
- $40.4M of $74.7M sold (54%)
Who traded IMAX, and when
- Sale
- Sale, pre-arranged (10b5-1)
IMAX daily close from Oct 24, 2025 to Oct 23, 2026, between $31.70 and $56.33, last $53.38. 21 sale and 0 purchase filings by 10 insiders, marked at their filing dates. Richard L. Gelfond, Chief Executive Officer: sold $42.6M across 7 filings, first filed Mar 12, 2026, last Aug 20, 2026. James E. Douglas III, Other: sold $19.8M across 1 filing, first filed Mar 17, 2026, last Mar 17, 2026. Mark Welton, President IMAX Global Theatres: sold $4.4M across 3 filings, first filed Nov 10, 2025, last Aug 26, 2026. Robert D. Lister, Chief Legal Officer Sr Exec VP: sold $2.9M across 2 filings, first filed Nov 7, 2025, last Sep 11, 2026. Kevin Douglas, Director: sold $1.7M across 1 filing, first filed Mar 17, 2026, last Mar 17, 2026. Calamera Pablo, CTO & EVP: sold $1.5M across 2 filings, first filed Nov 10, 2025, last Aug 21, 2026. 4 others: sold $1.9M across 5 filings, first filed Nov 10, 2025, last Aug 26, 2026.
Largest mark · tap a row for others
Richard L. Gelfond · Chief Executive Officer
Sale $23,984,308
456,757 shares at $52.51 avg
Filed Aug 20, 2026 · traded Aug 18
Pre-arranged (10b5-1) · close on filing date $52.74
Richard L. Gelfond · Chief Executive Officer
Chief Executive Officer
$42.6M soldJames E. Douglas III · Other
Other
$19.8M soldMark Welton · President IMAX Global Theatres
President IMAX Global Theatres
$4.4M soldRobert D. Lister · Chief Legal Officer Sr Exec VP
Chief Legal Officer Sr Exec VP
$2.9M soldKevin Douglas · Director
Director
$1.7M soldCalamera Pablo · CTO & EVP
CTO & EVP
$1.5M sold4 others
Combined, one mark per week
$1.9M soldHas Imax Corp's CEO sold stock?
Yes. Richard L. Gelfond (CEO) sold 943,041 shares ($42.6M) between Mar 2026 and Aug 2026, $37.7M of it under a pre-arranged 10b5-1 plan. Daniel Manwaring (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
21 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Richard L. Gelfond | Chief Executive Officer | $42.6M | — | 7 | 89% of sales | |
| James E. Douglas III | Other | $19.8M | — | 1 | — | |
| Mark Welton | President IMAX Global Theatres | $4.4M | — | 3 | 23% of sales | |
| Robert D. Lister | Chief Legal Officer Sr Exec VP | $2.9M | — | 2 | 60% of sales | |
| Kevin Douglas | Director | $1.7M | — | 1 | — | |
| Calamera Pablo | CTO & EVP | $1.5M | — | 2 | — | |
| Natasha Fernandes | Chief Financial Officer & EVP | $1.2M | — | 2 | — | |
| Kenneth Ian Weissman | Deputy GC, Corp. Sec. & CCO | $436.3K | — | 1 | — | |
| Giovanni M. Dolci | Chief Commercial Officer & EVP | $211.9K | — | 1 | — | |
| Jose Aleksandr Zlatar | SVP, Controller & PAO | $25.0K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Robert D. Lister Chief Legal Officer Sr Exec VP | Sale | 22,500 | $51.58 | $1.2M | 182,375 | |
traded | Natasha Fernandes Chief Financial Officer & EVP | Sale | 20,000 | $54.63 | $1.1M | 35,596 | |
traded | Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO | Sale | 8,000 | $54.54 | $436.3K | 28,205 | |
traded | Mark Welton President IMAX Global Theatres | Sale | 30,000 | $54.47 | $1.6M | 143,216 | |
traded | Calamera Pablo CTO & EVP | Sale | 15,000 | $52.41 | $786.2K | 43,012 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 456,757 | $52.51 | $24.0M | 665,002 | |
traded | Jose Aleksandr Zlatar SVP, Controller & PAO | Sale | 500 | $49.90 | $25.0K | 583 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 8,943 | $37.33 | $333.8K | 765,002 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 75,919 | $37.05 | $2.8M | 765,002 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 120,132 | $37.14 | $4.5M | 765,002 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 135,046 | $37.82 | $5.1M | 765,002 | |
traded | Richard L. Gelfond Chief Executive Officer | SalePre-arranged (10b5-1) | 25,024 | $40.14 | $1.0M | 765,002 | |
traded | James E. Douglas III Other | Sale | 524,200 | $37.82 | $19.8M | Multiple accounts | |
traded | Kevin Douglas Director | Sale | 43,800 | $37.82 | $1.7M | 602,311 | |
traded | Richard L. Gelfond Chief Executive Officer | Sale | 121,220 | $40.10 | $4.9M | 765,002 | |
traded | Mark Welton President IMAX Global Theatres | SalePre-arranged (10b5-1) | 25,000 | $39.28 | $982.0K | 128,323 | |
traded | Natasha Fernandes Chief Financial Officer & EVP | Sale | 2,652 | $36.15 | $95.9K | 31,257 | |
traded | Calamera Pablo CTO & EVP | Sale | 20,586 | $34.23 | $704.6K | 40,886 | |
traded | Giovanni M. Dolci Chief Commercial Officer & EVP | Sale | 6,188 | $34.25 | $211.9K | 33,000 | |
traded | Mark Welton President IMAX Global Theatres | Sale | 49,504 | $35.23 | $1.7M | 153,323 | |
traded | Robert D. Lister Chief Legal Officer Sr Exec VP | SalePre-arranged (10b5-1) | 50,143 | $34.67 | $1.7M | 161,421 |
GET /stocks/filings/vX/form-4?tickers=IMAX&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"IMAX"
],
"issuer_cik": "0000921582",
"owner_cik": "0001255900",
"accession_number": "0001214659-26-011612",
"form_type": "4",
"filing_date": "2026-09-11",
"period_of_report": "2026-09-10",
"issuer_name": "IMAX CORP",
"issuer_trading_symbol": "IMAX",
"owner_name": "LISTER ROBERT D",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Legal Officer Sr Exec VP",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "common shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-10",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 22500,
"transaction_price_per_share": 51.5812,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 182375,
"transaction_value": 1160577,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Mr. Lister's aggregate remaining outstanding restricted share unit and common share balances following this transaction will be 53,272 and 182,375, respectively."
}
]
},
{
"tickers": [
"IMAX"
],
"issuer_cik": "0000921582",
"owner_cik": "0001928296",
"accession_number": "0001214659-26-010908",
"form_type": "4",
"filing_date": "2026-08-26",
"period_of_report": "2026-08-24",
"issuer_name": "IMAX CORP",
"issuer_trading_symbol": "IMAX",
"owner_name": "Fernandes Natasha",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Financial Officer & EVP",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "common shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-24",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 54.6277,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 35596,
"transaction_value": 1092554,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Ms. Fernandes' aggregate remaining restricted share unit and common share balances following these transactions will be 32,764 and 35,596, respectively."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 95 records
- Option exercises39 records
- Tax withholding25 records
- Grants and awards13 records
- Gifts2 records
- Other16 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for IMAX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.